ATWLPPR peptide TFA

Cat. No: CDIA-0660

Size: 10 mg

Price: Inquiry

Product Details
Formula	C42H62F3N11O11
Molecular Weight	954.00
Appearance	Solid
Purity	99.34%
Smiles String	O=C(N[[email protected]@H]([[email protected]](O)C)C(N[[email protected]@H](CC1=CNC2=CC=CC=C12)C(N[[email protected]@H](CC(C)C)C(N3[[email protected]@H](CCC3)C(N4[[email protected]@H](CCC4)C(N[[email protected]@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)[[email protected]](C)N.OC(C(F)(F)F)=O

Storage & Handling
Shipping	Room temperature.
Storage	Sealed storage, away from moisture and light *In solvent : -80 °C, 6 months; -20 °C, 1 month (sealed storage, away from moisture and light)
Storage Powder	-80 °C/2 years, -20 °C/1 year

Description

ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.

! For research use only. Not intended for any clinical use.